Advertisement
    In the last 2 hours
    In the last 8 hours
    Yesterday
    In the last 7 days
    Movers and Shakers: Levodopa in Africa Rory Cellan-Jones06:56 6-Dec-25
    In the last month
    Save the date: Health and Information Talk on Parkinson's Disease University Hospitals of Derby and Burton NHS (Press Release)08:32 1-Dec-25
    Movers and Shakers: The MegaTrial Rory Cellan-Jones06:23 29-Nov-25
    Movers and Shakers: The Parky Charter Debate Rory Cellan-Jones05:42 22-Nov-25
    Can AI ‘Griefbots’ Help Us Heal? Scientific American09:00 18-Nov-25
    Movers and Shakers: The Funding Machine Rory Cellan-Jones02:53 17-Nov-25
    R&D 100 winners increasing access to care for Parkinson’s Drug Discovery & Development17:51 13-Nov-25
    A $1 billion question about Parkinson’s Rory Cellan-Jones05:11 12-Nov-25
    Adults living with Parkinson’s disease across the Fylde Coast may soon be offered a life-changing treatment for… Blackpool Teaching Hospitals NHS Foundation Trust (Press Release)04:45 12-Nov-25
    view more headlines
    9 Dec 14:46

    About our Parkinson's Disease news

    Latest news on Parkinson's, covering breakthrough treatments, research updates, symptoms, clinical trials, early detection, and living with the disease.

    Parkinson's disease affects more than 10 million people worldwide, making it the second most common neurodegenerative disorder after Alzheimer's. This progressive nervous system disorder, which primarily impacts movement, continues to be the focus of intensive research efforts by leading institutions including the Michael J. Fox Foundation, the Parkinson's Foundation, and numerous medical research centres globally.

    Recent advances in treatment options have shown promising results, with new medications and therapies being developed to better manage symptoms and potentially slow disease progression. Researchers are exploring innovative approaches such as gene therapy, stem cell treatments, and precision medicine, while also investigating the role of environmental factors and genetic markers in disease development.

    Beyond the medical aspects, community support networks and advocacy groups play a crucial role in improving quality of life for those affected by Parkinson's. Patient organisations worldwide organise awareness campaigns, support groups, and educational programmes, helping both patients and caregivers navigate the challenges of living with the condition. Exercise programmes specifically designed for Parkinson's patients, such as boxing classes and dance therapy, have shown remarkable benefits in maintaining mobility and social connection.

    First described by Dr James Parkinson in 1817 in his "Essay on the Shaking Palsy", understanding of the disease has evolved significantly. The discovery of dopamine's role in the 1960s marked a major breakthrough, leading to the development of levodopa, which remains a cornerstone of treatment. Historical figures such as Muhammad Ali and Michael J. Fox have raised public awareness and contributed to advancing research through their foundations and advocacy work.

    Our NewsNow feed provides comprehensive coverage of Parkinson's disease developments, from the latest research breakthroughs to practical advice for patients and caregivers. Whether you're a healthcare professional, researcher, patient, or family member, staying informed about advances in treatment, clinical trials, and support resources is crucial for understanding and managing this complex condition.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.